Biological Therapy for Inflammatory Bowel Disease

Biological therapy for inflammatory bowel disease uses medications called biopharmaceuticals or biologics that are tailored to target a specific immune or genetic mediator of the disease. Even when the underlying cause of inflammatory bowel disease is unknown, molecules involved in the disease process, mainly cytokines directly tied to the immune system, can be identified and targeted with these treatments. Biological therapy has become an established approach in the management of inflammatory bowel disease alongside its use for other autoimmune conditions and cancer.